Depression & Anxiety
The ICHOM Standard Set for Depression & Anxiety is the result of hard work by a group of leading physicians, measurement experts, and patients. It represents the outcomes that matter most to patients with depression and/or anxiety. We urge all providers around the world to start measuring these outcomes to better understand how to improve the lives of their patients.
- Recommended to track via the Patient Health Questionnaire (PHQ-9).
- Includes symptoms of general anxiety, social phobia, agoraphobia, post-traumatic stress disorder, panic disorder, and obsessive-compulsive disorder.
- Recommended to track via the Generalized Anxiety Disorder (GAD-7), and for those with specific anxiety disorders: the Social Phobia Inventory (SPIN), the Mobility Inventory for Agoraphobia (MIA), the Impact of Event Scale – Revised for Post-Traumatic Stress Disorder (IES-R), the Panic Disorder Severity Scale (PDSS-SR), and the Obsessive-Compulsive Inventory (OCI-R).
- Recommended to track via the World Health Organization Disability Assessment 2.0 (WHODAS 2.0).
- Includes work status and disease-related absenteeism.
Resource Documents
Depression & Anxiety community group
The ICHOM Standard Set for Depression & Anxiety is the result of hard work by a group of leading physicians, measurement experts, and patients.
Team that developed this standard
AUSTRALIA
Maria Kangas | Centre for Emotional Health, Macquarie University
BRAZIL
Roberta Alvarenga Reis | Universidade Federal do Rio Grande do Sul
CANADA
Anne Crocker | Douglas Mental Health University Institute, McGill University
Lucie Langford*
Alain Lesage | University of Montreal
CHILE
Graciela Rojas | University of Chile
GERMANY
Sandra Nolte | Charité Universitätsmedizin Berlin
Alexander Obbarius | Charité Universitätsmedizin Berlin
Matthias Rose | Charité Universitätsmedizin Berlin
INDIA
Vikram Patel | London School of Hygiene and Tropical Medicine
JAPAN
Toshi A. Furukawa | Kyoto University
NETHERLANDS
Edwin de Beurs | Stichting Benchmark GGZ
Paul Emmelkamp | University of Amsterdam
SWEDEN
Erik Hedman | Karolinska Institutet
UGANDA
Doris M. Mwesigire | Makerere University
UNITED KINGDOM
David M. Clark | University of Oxford
David Smithson* | Anxiety UK
UNITED STATES
Lee Baer | Harvard Medical School; Massachusetts General Hospital
Kelly Woolaway-Bickel | Department of the U.S. Army, Office of the Surgeon General
Paul A. Pilkonis | University of Pittsburgh
Harold A. Pincus | Columbia University
Cathy Sherbourne | The RAND Corporation
* Patient representative
